124 related articles for article (PubMed ID: 27416002)
1. Novel immune assay for quantification of plasma protective capacity against oxidized phospholipids.
Bochkov V; Schoenenberger AW; Oskolkova O; Toth U; Stöckl J; Majdic O; Daci A; Resink TJ; Erne P; Philippova M
Biomark Med; 2016 Aug; 10(8):797-810. PubMed ID: 27416002
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a): short-term and long-term immunologic responses to oxidized low-density lipoprotein.
Tsimikas S; Lau HK; Han KR; Shortal B; Miller ER; Segev A; Curtiss LK; Witztum JL; Strauss BH
Circulation; 2004 Jun; 109(25):3164-70. PubMed ID: 15184281
[TBL] [Abstract][Full Text] [Related]
3. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
Tsimikas S; Witztum JL; Miller ER; Sasiela WJ; Szarek M; Olsson AG; Schwartz GG;
Circulation; 2004 Sep; 110(11):1406-12. PubMed ID: 15353498
[TBL] [Abstract][Full Text] [Related]
4. The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.
Fefer P; Tsimikas S; Segev A; Sparkes J; Otsuka F; Kolodgie F; Virmani R; Juliano J; Charron T; Strauss BH
Cardiovasc Revasc Med; 2012; 13(1):11-9. PubMed ID: 22079685
[TBL] [Abstract][Full Text] [Related]
5. Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice.
Que X; Hung MY; Yeang C; Gonen A; Prohaska TA; Sun X; Diehl C; Määttä A; Gaddis DE; Bowden K; Pattison J; MacDonald JG; Ylä-Herttuala S; Mellon PL; Hedrick CC; Ley K; Miller YI; Glass CK; Peterson KL; Binder CJ; Tsimikas S; Witztum JL
Nature; 2018 Jun; 558(7709):301-306. PubMed ID: 29875409
[TBL] [Abstract][Full Text] [Related]
6. Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes.
Tsimikas S; Bergmark C; Beyer RW; Patel R; Pattison J; Miller E; Juliano J; Witztum JL
J Am Coll Cardiol; 2003 Feb; 41(3):360-70. PubMed ID: 12575961
[TBL] [Abstract][Full Text] [Related]
7. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
[TBL] [Abstract][Full Text] [Related]
8. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
9. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
[TBL] [Abstract][Full Text] [Related]
10. OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients.
Bossola M; Tazza L; Luciani G; Tortorelli A; Tsimikas S
J Nephrol; 2011; 24(5):581-8. PubMed ID: 21404224
[TBL] [Abstract][Full Text] [Related]
11. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.
Trpkovic A; Resanovic I; Stanimirovic J; Radak D; Mousa SA; Cenic-Milosevic D; Jevremovic D; Isenovic ER
Crit Rev Clin Lab Sci; 2015; 52(2):70-85. PubMed ID: 25537066
[TBL] [Abstract][Full Text] [Related]
12. Heritability of Biomarkers of Oxidized Lipoproteins: Twin Pair Study.
Rao F; Schork AJ; Maihofer AX; Nievergelt CM; Marcovina SM; Miller ER; Witztum JL; O'Connor DT; Tsimikas S
Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1704-11. PubMed ID: 25953646
[TBL] [Abstract][Full Text] [Related]
13. Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.
Taleb A; Witztum JL; Tsimikas S
Biomark Med; 2011 Oct; 5(5):673-94. PubMed ID: 22003918
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma oxidized phospholipid:apolipoprotein B-100 ratio with concomitant depletion of oxidized phospholipids from atherosclerotic lesions after dietary lipid-lowering: a potential biomarker of early atherosclerosis regression.
Tsimikas S; Aikawa M; Miller FJ; Miller ER; Torzewski M; Lentz SR; Bergmark C; Heistad DD; Libby P; Witztum JL
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):175-81. PubMed ID: 17082490
[TBL] [Abstract][Full Text] [Related]
15. Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.
Ravandi A; Leibundgut G; Hung MY; Patel M; Hutchins PM; Murphy RC; Prasad A; Mahmud E; Miller YI; Dennis EA; Witztum JL; Tsimikas S
J Am Coll Cardiol; 2014 May; 63(19):1961-71. PubMed ID: 24613321
[TBL] [Abstract][Full Text] [Related]
16. A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma.
Bergmark C; Dewan A; Orsoni A; Merki E; Miller ER; Shin MJ; Binder CJ; Hörkkö S; Krauss RM; Chapman MJ; Witztum JL; Tsimikas S
J Lipid Res; 2008 Oct; 49(10):2230-9. PubMed ID: 18594118
[TBL] [Abstract][Full Text] [Related]
17. Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.
Kothari H; Nguyen AT; Yang X; Hisada Y; Tsimikas S; Mackman N; Taylor A; McNamara CA
J Cardiovasc Transl Res; 2018 Jun; 11(3):221-229. PubMed ID: 29344841
[TBL] [Abstract][Full Text] [Related]
18. Accumulation of Plasma-Derived Lipids in the Lipid Core and Necrotic Core of Human Atheroma: Imaging Mass Spectrometry and Histopathological Analyses.
Nakagawa K; Tanaka M; Hahm TH; Nguyen HN; Matsui T; Chen YX; Nakashima Y
Arterioscler Thromb Vasc Biol; 2021 Nov; 41(11):e498-e511. PubMed ID: 34470476
[TBL] [Abstract][Full Text] [Related]
19. Analysis of fragmented oxidized phosphatidylcholines in human plasma using mass spectrometry: Comparison with immune assays.
Philippova M; Oskolkova OV; Bicker W; Schoenenberger AW; Resink TJ; Erne P; Bochkov VN
Free Radic Biol Med; 2019 Nov; 144():167-175. PubMed ID: 31141712
[TBL] [Abstract][Full Text] [Related]
20. Characterization of covalent modifications of HDL apoproteins by endogenous oxidized phospholipids.
Gao D; Podrez EA
Free Radic Biol Med; 2018 Feb; 115():57-67. PubMed ID: 29155052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
